✨ Free AI Report
Jubilant Pharmova Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Jubilant Pharmova Limited
Company Research

Jubilant Pharmova Limited: Business Overview, Financials & Competitive Analysis

Jubilant Pharmova is an integrated pharmaceutical company operating in India, the Americas, Europe, and internationally across six segments: Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing f...

Analyst-debate audio for Jubilant Pharmova Limited

AskCyborg analysts argue the bull and bear cases for Jubilant Pharmova Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Established specialty pharma player with strong US market positions in radiopharmaceuticals and allergy immunotherapy, but...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Biotechnology - Specialty Pharma & Contract Manufacturing
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Jubilant Pharmova Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Jubilant Pharmova Limited Overview

Pro stress-test →

Jubilant Pharmova is an integrated pharmaceutical company operating in India, the Americas, Europe, and internationally across six segments: Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing for Sterile Injectables, Generics, Contract Research Development and Manufacturing, and Proprietary Novel Drugs. The company targets multiple healthcare sectors including pharmaceutical companies, biotech firms, allergists, and hospitals.

Strategic Profile

Pro stress-test →

The company holds the second largest commercial radio pharmacy network in the US and is the second largest in the allergenic extract market in the US. Radiopharma contributes approximately 44% of revenue and the company ranks as the #3 radiopharmaceutical manufacturer in the US, positioning it as a significant player in specialty pharmaceuticals and contract services.

Competitive Landscape

Pro stress-test →

In the US market, Jubilant Pharmova is the second largest radiopharmaceutical company by network size and the second largest allergenic extract manufacturer. Primary competitors include larger integrated pharma companies like Lantheus Medical, Novartis, and Allergan. The contract manufacturing segment faces competition from larger CDMOs like Lonza and Recro Pharma.

Industry Context

Jubilant Pharmova Limited operates in Pharmaceuticals & Biotechnology - Specialty Pharma & Contract Manufacturing.

Key facts

Founded: 1978 · Headquarters: Noida, India · Employees: 174,012 · Market cap: ₹13,529 Cr ($1.6B USD approx)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Jubilant Pharmova Limited.

  • The company operates 46 radiopharmacies in the US, the #2 network in the nation
  • Working capital requirements have improved significantly, reducing from 43.0 days to 16.3 days
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2024 Q3RUBY-FILL cardiac imaging product and Mertiatide showing strong sales momentum
  • 2024Facility expansion in Spokane with third sterile-fill-finish manufacturing line operational
  • +1 moreTrack every material event for Jubilant Pharmova Limited as it happens. Explore monitoring →
Get alerted when Jubilant Pharmova Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Radiopharmaceutical productsLeading US diagnostic imaging pharmaceutical provider→Allergy immunotherapyMajor global allergy immunotherapy competitor→Sterile injectable CDMOGlobal leader in contract manufacturing services→

Compare Jubilant Pharmova Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Jubilant Pharmova Limited operates in Pharmaceuticals & Biotechnology - Specialty Pharma & Contract Manufacturing. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Biotechnology - Specialty Pharma & Contract Manufacturing research →
NEW · MCP server

Ask your AI assistant about Jubilant Pharmova Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Jubilant Pharmova Limited and its top competitor on Cyborg Score”
“What did Jubilant Pharmova Limited do this quarter?”
“Is Jubilant Pharmova Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Jubilant Pharmova Limited do?+
Jubilant Pharmova is an integrated pharmaceutical company operating in India, the Americas, Europe, and internationally across six segments: Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing f...
What is Jubilant Pharmova Limited's Cyborg Score?+
Jubilant Pharmova Limited has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Jubilant Pharmova Limited's main competitors?+
Named competitors include Radiopharmaceutical products, Allergy immunotherapy, Sterile injectable CDMO. The full competitive landscape is in the AskCyborg report.
How can I get the full Jubilant Pharmova Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Jubilant Pharmova Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Jubilant Pharmova Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.